Literature DB >> 21892064

FDG PET/CT demonstration of pancreatic metastasis from prostate cancer.

Bhushan Desai1, Wafaa Elatre, David I Quinn, Hossein Jadvar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21892064      PMCID： PMC3167095          DOI： 10.1097/RLU.0b013e3182291d1a

Source DB:  PubMed          Journal:  Clin Nucl Med        ISSN： 0363-9762            Impact factor:   7.794


× No keyword cloud information.
  7 in total

1.  Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients.

Authors:  L Bubendorf; A Schöpfer; U Wagner; G Sauter; H Moch; N Willi; T C Gasser; M J Mihatsch
Journal:  Hum Pathol       Date:  2000-05       Impact factor: 3.466

2.  C11-acetate and F-18 FDG PET for men with prostate cancer bone metastases: relative findings and response to therapy.

Authors:  Evan Y Yu; Mark Muzi; Joy A Hackenbracht; Brian B Rezvani; Jeanne M Link; Robert Bruce Montgomery; Celestia S Higano; Janet F Eary; David A Mankoff
Journal:  Clin Nucl Med       Date:  2011-03       Impact factor: 7.794

3.  Synchronous prostate cancer incidentally detected by FDG-PET/CT in staging a patient with newly diagnosed nasopharyngeal cancer.

Authors:  Guang-Uei Hung; Ching-Yeh Hsiung; Ming-Li Huang; Shang-Tao Lin
Journal:  Clin Nucl Med       Date:  2009-12       Impact factor: 7.794

Review 4.  Metastases to the pancreas.

Authors:  E M Merkle; T Boaz; O Kolokythas; J R Haaga; J S Lewin; H J Brambs
Journal:  Br J Radiol       Date:  1998-11       Impact factor: 3.039

5.  Features of unusual metastases from prostate cancer.

Authors:  M A Long; J E Husband
Journal:  Br J Radiol       Date:  1999-10       Impact factor: 3.039

6.  Pancreatic metastasis from prostate cancer.

Authors:  Julian Jacob; Cyrus Chargari; Olivier Bauduceau; Maryse Fayolle; Bernard Ceccaldi; Frédéric Prat; Sylvestre Le Moulec; Lionel Vedrine
Journal:  Case Rep Med       Date:  2010-05-23

Review 7.  Molecular imaging of prostate cancer with 18F-fluorodeoxyglucose PET.

Authors:  Hossein Jadvar
Journal:  Nat Rev Urol       Date:  2009-05-12       Impact factor: 14.432
  7 in total
  3 in total

1.  MR molecular imaging of prostate cancer with a peptide-targeted contrast agent in a mouse orthotopic prostate cancer model.

Authors:  Mingqian Tan; Susan M Burden-Gulley; Wen Li; Xueming Wu; Daniel Lindner; Susann M Brady-Kalnay; Vikas Gulani; Zheng-Rong Lu
Journal:  Pharm Res       Date:  2011-12-03       Impact factor: 4.200

2.  (18)F-FDG-PET/CT findings in pancreatic metastasis.

Authors:  Shengping Hu; Jian Zhang; Changjing Zuo; Chao Cheng; Qinghua Liu; Gaofeng Sun
Journal:  Radiol Med       Date:  2015-03-22       Impact factor: 3.469

Review 3.  Malignant biliary obstruction due to metastatic non-hepato-pancreato-biliary cancer.

Authors:  Takeshi Okamoto
Journal:  World J Gastroenterol       Date:  2022-03-14       Impact factor: 5.742
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.